CannTrust (TSE:TRST) was downgraded by analysts at Eight Capital from a “neutral” rating to a “sell” rating in a research note issued to investors on Friday, BayStreet.CA reports. They presently have a C$4.00 price target on the stock, down from their previous price target of C$6.00. Eight Capital’s price target suggests a potential upside of 19.76% from the company’s previous close.

TRST has been the subject of several other reports. Cormark boosted their price objective on shares of Parex Resources from C$32.50 to C$35.00 in a research report on Tuesday, July 9th. Bank of America restated a “buy” rating and set a C$11.00 price objective on shares of CannTrust in a research report on Friday, May 24th. Canaccord Genuity restated a “buy” rating on shares of Dart Group in a research report on Thursday. Finally, Jefferies Financial Group boosted their price objective on shares of Monster Beverage from $65.00 to $70.00 and gave the company a “buy” rating in a research report on Friday, May 3rd.

Shares of TRST opened at C$3.34 on Friday. CannTrust has a one year low of C$3.26 and a one year high of C$15.50. The firm has a market capitalization of $667.80 million and a P/E ratio of -27.60. The company has a current ratio of 5.64, a quick ratio of 1.90 and a debt-to-equity ratio of 8.20. The company’s 50 day moving average price is C$6.65.

About CannTrust

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

See Also: What are earnings reports?

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.